메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
저널정보
대한암예방학회 대한암예방학회지 대한암예방학회지 제16권 제3호
오류 신고하기

피인용 0

검색

    초록·키워드

    The transcriptional coactivator peroxisome proliferator-activated receptor coactivator-1α (PGC-1α/Ppargc1α) plays a central role in controlling and modulating the expression of mitochondrial genes. High levels of PGC-1α are linked to numerous pathological conditions and multiple pathways in relation with ROS detoxification, cancers, Alzheimer’s disease, stress response, circadian clock function, hepatic metabolism,strokes, cardiovascular diseases, Huntington’s disease and aging. PGC-1α has been cited as a potential new therapeutic target in the prevention of cancers and cardiovascular diseases by the mean of modulating the PGC-1α dependent-pathways using peptides targeting the Leu-Xaa-Xaa- Leu-Leu (LxxLL)domain of PGC-1α. LxxLL functional domain is key in many protein-protein interactions. New therapeutics are sorely needed to prevent and cure cancers along with the deterrence of cardiovascular diseases. In this study, using computational modeling tools, we provide structural insights into the design of small peptides to mimic the PGC-1α LxxLL domain to compete against PGC-1α in a bid to ultimately regulate the pathway. (Cancer Prev Res 16, 210-215, 2011)

    최근 본 자료 전체보기